Lantheus Holdings, Inc. (LNTH) Cash Flow Statement

The persistent gap between operating cash flow and net income, particularly in quarters like 2025Q3 (OCF/NI of 3.79) and 2024Q4 (where net income was negative but OCF was $155.4M), suggests that reported earnings understate cash generation. This may reflect significant non-cash charges or timing differences, but the consistency of the gap implies that cash earnings are more stable than GAAP net income. Investors should monitor whether this divergence narrows as growth slows.

The sharp rise in FCF margin, particularly in 2026Q2, appears driven by a combination of strong operating cash flow and minimal capex. However, this may not be sustainable if revenue growth continues to stagnate, as the absolute FCF levels could plateau. The comparison to net income shows that FCF is consistently higher, reinforcing the view that the company's cash-generating ability is stronger than its earnings suggest.

The consistently low capex-to-revenue ratio suggests that Lantheus operates with minimal fixed asset requirements, likely due to its specialty pharmaceutical model. This allows for high conversion of operating cash flow to free cash flow, but it also implies that growth may not require heavy investment, which could limit barriers to entry. The modest capex levels appear sufficient to maintain operations, but investors should watch for any step-up in spending that could signal a shift toward more capital-intensive initiatives.

The erratic working capital changes, including a large negative in 2024Q2 and positive in 2026Q2, appear to be driven by timing of receivables and payables rather than a systemic problem. The absence of a persistent build-up in inventory or receivables suggests that the company is managing its cycle effectively. However, the volatility could complicate short-term cash flow forecasting, and investors should monitor whether these swings become more pronounced as growth slows.

The company has been returning significant capital to shareholders through buybacks, with $100M in each of the last four quarters, while also making notable acquisition-related payments. This suggests a strategy of both returning cash and pursuing growth through M&A, though the net effect on cash reserves is unclear. The lack of dividends may indicate a preference for buybacks and reinvestment, but the sustainability of this pace depends on continued strong operating cash flow.

The persistent excess of operating cash flow over net income suggests that the company's earnings are understated, possibly due to non-cash charges or conservative revenue recognition. This divergence is a positive signal for cash flow quality, but it also raises questions about the sustainability of the gap. If the gap narrows, it could indicate a normalization of earnings, which might pressure the stock if investors have been valuing the company on cash flow.